← Open Payments lookup

GARY WARSTADT: Open Payments

NPI 1639155013 · RANDOLPH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$713 in 35 payments from 11 companies in 2025. Trend: 2023 $902 · 2024 $773 · 2025 $713

Food & beverage: $713
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$147
ABBVIE INC.7$142
Neurocrine BioSciences, Inc.4$85
E.R. Squibb & Sons, L.L.C.3$72
Vanda Pharmaceuticals Inc.3$69
Teva Pharmaceuticals USA, Inc.2$53
Otsuka America Pharmaceutical, Inc.2$42
Collegium Pharmaceutical, Inc.2$35
Lundbeck LLC1$26
Alkermes, Inc.1$24

Products named: CAPLYTA, VRAYLAR, INGREZZA, COBENFY, FANAPT, REXULTI, AUSTEDO XR, Jornay PM.

Industry payments across MA — which companies pay providers there.